Canada Life’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $435K | Buy |
11,726
+5,388
| +85% | +$174K | ﹤0.01% | 1515 |
|
|
2026
Q1 | $202K | Hold |
6,338
| – | – | ﹤0.01% | 1597 |
|
|
2025
Q4 | $172K | Hold |
6,338
| – | – | ﹤0.01% | 1641 |
|
|
2025
Q3 | $166K | Hold |
6,338
| – | – | ﹤0.01% | 1710 |
|
|
2025
Q2 | $129K | Hold |
6,338
| – | – | ﹤0.01% | 1739 |
|
|
2025
Q1 | $115K | Hold |
6,338
| – | – | ﹤0.01% | 1759 |
|
|
2024
Q4 | $160K | Hold |
6,338
| – | – | ﹤0.01% | 1757 |
|
|
2024
Q3 | $215K | Sell |
6,338
-7,279
| -53% | -$277K | ﹤0.01% | 1781 |
|
|
2024
Q2 | $505K | Buy |
13,617
+9,047
| +198% | +$341K | ﹤0.01% | 1677 |
|
|
2024
Q1 | $192K | Buy |
4,570
+955
| +26% | +$39.2K | ﹤0.01% | 1834 |
|
|
2023
Q4 | $142K | Hold |
3,615
| – | – | ﹤0.01% | 1884 |
|
|
2023
Q3 | $99K | Buy |
3,615
+1,914
| +113% | +$60K | ﹤0.01% | 1964 |
|
|
2023
Q2 | $58K | Hold |
1,701
| – | – | ﹤0.01% | 1987 |
|
|
2023
Q1 | $61K | Sell |
1,701
-369
| -18% | -$15.9K | ﹤0.01% | 2037 |
|
|
2022
Q4 | $93K | Hold |
2,070
| – | – | ﹤0.01% | 2000 |
|
|
2022
Q3 | $58K | Hold |
2,070
| – | – | ﹤0.01% | 2070 |
|
|
2022
Q2 | $56K | Hold |
2,070
| – | – | ﹤0.01% | 2038 |
|
|
2022
Q1 | $75K | Hold |
2,070
| – | – | ﹤0.01% | 2065 |
|
|
2021
Q4 | $80K | Hold |
2,070
| – | – | ﹤0.01% | 2060 |
|
|
2021
Q3 | $113K | Sell |
2,070
-480
| -19% | -$22.5K | ﹤0.01% | 2028 |
|
|
2021
Q2 | $85K | Hold |
2,550
| – | – | ﹤0.01% | 2127 |
|
|
2021
Q1 | $52K | Hold |
2,550
| – | – | ﹤0.01% | 2275 |
|
|
2020
Q4 | $45K | Buy |
+2,550
| New | +$45.9K | ﹤0.01% | 2316 |
|
|
2018
Q2 | – | Sell |
-685
| Closed | -$24K | – | 2717 |
|
|
2018
Q1 | $24K | Hold |
685
| – | – | ﹤0.01% | 2486 |
|
|
2017
Q4 | $29K | Hold |
685
| – | – | ﹤0.01% | 2454 |
|
|
2017
Q3 | $29K | Hold |
685
| – | – | ﹤0.01% | 2439 |
|
|
2017
Q2 | $25K | Hold |
685
| – | – | ﹤0.01% | 2469 |
|
|
2017
Q1 | $37K | Hold |
685
| – | – | ﹤0.01% | 2373 |
|
|
2016
Q4 | $37K | Hold |
685
| – | – | ﹤0.01% | 2386 |
|
|
2016
Q3 | $41K | Hold |
685
| – | – | ﹤0.01% | 2368 |
|
|
2016
Q2 | $45K | Hold |
685
| – | – | ﹤0.01% | 2335 |
|
|
2016
Q1 | $39K | Hold |
685
| – | – | ﹤0.01% | 2205 |
|
|
2015
Q4 | $161K | Hold |
685
| – | – | ﹤0.01% | 1414 |
|
|
2015
Q3 | $109K | Hold |
685
| – | – | ﹤0.01% | 1640 |
|
|
2015
Q2 | $259K | Hold |
685
| – | – | ﹤0.01% | 1243 |
|
|
2015
Q1 | $286K | Hold |
685
| – | – | ﹤0.01% | 1164 |
|
|
2014
Q4 | $187K | Hold |
685
| – | – | ﹤0.01% | 1339 |
|
|
2014
Q3 | $134K | Buy |
685
+398
| +139% | +$86.7K | ﹤0.01% | 1459 |
|
|
2014
Q2 | $70K | Hold |
287
| – | – | ﹤0.01% | 1767 |
|
|
2014
Q1 | $75K | Hold |
287
| – | – | ﹤0.01% | 1552 |
|
|
2013
Q4 | $105K | Buy |
+287
| New | +$111K | ﹤0.01% | 1402 |
|
Other funds holding CLDX
KCM
DTC
LGM
Canada Life's CLDX Position: Q2 2026 in Review
Canada Life increased its Celldex Therapeutics (CLDX) stake by 85% in Q2 2026, buying an estimated $174K and bringing the position to 11,726 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.
Canada Life first reported a position in CLDX in Q4 2013 and has held it in 41 quarters since. The position peaked at $505K in Q2 2024. 254 funds tracked by Wall St. Rank hold CLDX as of Q2 2026.
- Canada Life held 11,726 shares of Celldex Therapeutics worth $435K as of Q2 2026.
- Canada Life bought 5,388 Celldex Therapeutics shares in Q2 2026, an estimated $174K.
- Celldex Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1515 holding.
- Canada Life first reported a position in Celldex Therapeutics in Q4 2013 and has held it in 41 quarters since.
- Canada Life's Celldex Therapeutics position peaked at $505K in Q2 2024.
- 254 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2026.
Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.